Primary study · included by 1 review

Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling.

Zakaria 2022 · Zakaria Sarah Sabrina, Ramanathan Anand, Mat Ripen Zakiah, et al. · Medicina (Kaunas, Lithuania) · 2022

Included by

Prognostic value of NLR versus PLR and LMR in patients with oral squamous cell carcinoma: a meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Zakaria 2022 · Table 1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.